Journal ArticleOPEN ACCESS

Comparative Trial of Nafoxidine and Ethinyloestradiol in Advanced Breast Cancer: An E.O.R.T.C. Study

British Medical Journal (1975) 2(5973) 711-713
DOI: 10.1136/bmj.2.5973.711
49Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

A randomized clinical trial of nafoxidine, a non–steroidal oestrogen antagonist, and ethinyloestradiol in postmenopausal patients with advanced breast cancer produced objective remissions in 31% of 49 women receiving nafoxidine and in 14% of 49 receiving ethinyloestradiol. The difference in remission rates was almost significant (0.05

Cite

CITATION STYLE

APA

Heuson, J. C., Engelsman, E., Blonk-Van Der Wijst, J., Maass, H., Nowakowski, H., Drochmans, A., … Gorins, A. (1975). Comparative Trial of Nafoxidine and Ethinyloestradiol in Advanced Breast Cancer: An E.O.R.T.C. Study. British Medical Journal, 2(5973), 711–713. https://doi.org/10.1136/bmj.2.5973.711

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free